Qiddiya City, Saudi Arabia's Premier Entertainment, Sports and Culture Destination, Elevates Guest Experience with accesso® Horizon
ORLANDO, Fla., April 9, 2025 /PRNewswire/ — accesso Technology Group (AIM: ACSO), the premier technology solutions …
ORLANDO, Fla., April 9, 2025 /PRNewswire/ — accesso Technology Group (AIM: ACSO), the premier technology solutions …
Kia’s Plan S 2030 business strategy updated with growth strategies for new products, focus on electrification commi…
CUBE’s new product combines the best of CUBE into a simple solution for a growing market LONDON, April 9, 2025 /PRN…
Harneys Fiduciary Joins Forces with Ascentium in Expanding Global Presence and Service Offerings SINGAPORE, April 9, 2025…
SHENZHEN, China, April 9, 2025 /PRNewswire/ — The 17th China International Battery Fair (CIBF2025) is set to t…
Watch the full interview on Visionaries, airing on CNN International on Saturday 12th April HONG KONG, April 9, 2025 /PRN…
Jointly expanding convenient and diverse online financial management options HONG KONG, April 9, 2025 /PRNewswire/ —…
YONGIN, South Korea, April 9, 2025 /PRNewswire/ — GC Biopharma announced 09. Apr. 2025 that the Korean Ministry of …
MELBOURNE, Australia, April 9, 2025 /PRNewswire/ — Hejaz, Australia’s leading Islamic financial services…
Unveiling its latest climate resilient solution for the first time in the Asia Pacific region at Sydney’s Smart Ene…
MUMBAI, India and SYDNEY, April 9, 2025 /PRNewswire/ — STL (NSE: STLTECH), a leading optical and digital solut…
VANCOUVER, BC, April 9, 2025 /PRNewswire/ — As storytelling becomes an essential skill for marketing professionals,…
New collaboration enables convenient and secure remittances to Weixin Pay users in China SINGAPORE, April 9, 2025 /P…
Five-year strategic partnership to improve patient care Focus on developing new technologies, improving diagnostics and t…
Enjoy an anniversary discount on the all-time classic in April SINGAPORE, April 9, 2025 /PRNewswire/ — One of …
YANTAI, China, April 9, 2025 /PRNewswire/ — On April 8, 2025 (UTC-7), impressive results of the Phase 3 clinic…